Mónica Toledano-Donado

Mónica Toledano-Donado

Auto-generated profile, based on publicly available information

Mónica Toledano-Donado

Mechanoadaptation and Caveolae Biology Lab (I.R.-A., F.-N.L., M.T.-D., M.P.-A., M.A.d.P.), Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMaría C. M. Aboy-Pardal
María C. M. Aboy-Pardal
MGMarta C. Guadamillas
Marta C. Guadamillas
CGCarlos R. Guerrero
Carlos R. Guerrero
MCMauro Català-Montoro
Mauro Català-Montoro
MTMónica Toledano-Donado
Mónica Toledano-Donado
MPMiguel A. del Pozo
Miguel A. del Pozo
Adipocytes expand massively to accommodate excess energy stores and protect the organism from lipotoxicity. Adipose tissue expandability is at the center of disorders such as obesity and lipodystrophy; however, little is known about the relevance of adipocyte biomechanics on the etiology of these conditions. Here, we show in male mice in vivo that the adipocyte plasma membrane undergoes caveolar domain reorganization upon lipid droplet expansion. As the lipid droplet grows, caveolae disassemble to release their membrane reservoir and increase cell surface area, and transfer specific caveolar components to the LD surface. Adipose tissue null for caveolae is stiffer, shows compromised deformability, and is prone to rupture under mechanical compression. Mechanistically, phosphoacceptor Cav1 Tyr14 is required for caveolae disassembly: adipocytes bearing a Tyr14Phe mutation at this residue are stiffer and smaller, leading to decreased adiposity in vivo; exhibit deficient transfer of Cav1 and EHD2 to the LD surface, and show distinct Cav1 molecular dynamics and tension adaptation. These results indicate that Cav1 phosphoregulation modulates caveolar dynamics as a relevant component of the homeostatic mechanoadaptation of the differentiated adipocyte.

1 February 2026 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
RMRocío Muñiz-Anquela
Rocío Muñiz-Anquela
IRIbon Redondo-Angulo
Ibon Redondo-Angulo
ELEsmeralda A. Lewis
Esmeralda A. Lewis
FLFidel-Nicolás Lolo
Fidel-Nicolás Lolo
LGLeticia González-Cintado
Leticia González-Cintado
JBJacob Fog Bentzon
Jacob Fog Bentzon
BACKGROUND: Eradicating endothelial caveolae by deleting the Cav1 (caveolin-1) gene reduces LDL (low-density lipoprotein) uptake in arteries and efficiently prevents early atherogenesis, but the role in established atherosclerosis is unknown. Here, to examine CAV1 as a potential therapeutic target, we deleted endothelial Cav1 in mice after lesion development and analyzed the effect on LDL uptake and lesion progression. METHODS: To allow timed endothelium-specific Cav1 deletion, we generated male and female mice with floxed Cav1 alleles and endothelium-specific inducible Cre recombinase. Atherosclerosis was induced by virus-mediated PCSK9 (proprotein convertase subtilisin/kexin type 9) gene transfer and a high-cholesterol diet. After 16 weeks of lesion development, endothelial Cav1 deletion was induced by a series of tamoxifen injections, repeated after 4 weeks, and the mice were followed for another 4 weeks. Mice were injected with fluorescently labeled LDL at 1 and 18 hours before euthanasia to study uptake and retention in lesions. Sections of the aortic root were analyzed for lesion size, composition, and LDL accumulation. RESULTS: Efficient conditional knockout of endothelial Cav1 was confirmed by CAV1 immunostaining and by the loss of caveolae by electron microscopy. Loss of endothelial Cav1 for 8 weeks reduced LDL entry into lesions but did not significantly decrease LDL retention, lesion lipid accumulation, fibrous tissue, or lesion size. In males, a reduction in macrophages was seen. CONCLUSIONS: Targeting CAV1 does not efficiently block LDL entry or reduce lesion progression in established atherosclerosis. These findings open several questions for further research, including alternative LDL entry mechanisms that could circumvent caveolar transport in established atherosclerosis.